Yoshiaki Monden

1.2k total citations
19 papers, 1.1k citations indexed

About

Yoshiaki Monden is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yoshiaki Monden has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yoshiaki Monden's work include DNA Repair Mechanisms (4 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Yoshiaki Monden is often cited by papers focused on DNA Repair Mechanisms (4 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Yoshiaki Monden collaborates with scholars based in Japan, United States and United Kingdom. Yoshiaki Monden's co-authors include Hiroharu Arakawa, Tomoko Yoshinari, Hirofumi Oka, Akira Okura, Susumu Nishimura, Hiroyuki Aburatani, Tsuyoshi Arai, Hiroshi Takano, Tetsuo Noda and Masanori Hirano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Oncogene.

In The Last Decade

Yoshiaki Monden

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiaki Monden Japan 11 764 268 229 184 147 19 1.1k
Elisabeth Strunck Germany 10 435 0.6× 142 0.5× 254 1.1× 254 1.4× 80 0.5× 15 978
Michitaka Numoto Japan 12 382 0.5× 182 0.7× 82 0.4× 111 0.6× 98 0.7× 15 622
Debra L. Bemis United States 13 557 0.7× 87 0.3× 165 0.7× 69 0.4× 189 1.3× 21 1.0k
Shigetoshi Hosaka Japan 16 409 0.5× 188 0.7× 202 0.9× 55 0.3× 123 0.8× 48 894
Rhoderick H. Elder United Kingdom 23 1.1k 1.5× 105 0.4× 338 1.5× 122 0.7× 172 1.2× 39 1.4k
Adil Akhtar United States 7 552 0.7× 218 0.8× 186 0.8× 127 0.7× 476 3.2× 20 1.2k
P Kolachana United States 7 599 0.8× 143 0.5× 358 1.6× 128 0.7× 158 1.1× 10 919
C. Richard Boland United States 12 615 0.8× 175 0.7× 318 1.4× 98 0.5× 165 1.1× 28 1.1k
Sara Antonia Li United States 21 680 0.9× 75 0.3× 213 0.9× 590 3.2× 262 1.8× 38 1.2k
Jerome F. Sah United States 7 424 0.6× 251 0.9× 106 0.5× 52 0.3× 226 1.5× 9 814

Countries citing papers authored by Yoshiaki Monden

Since Specialization
Citations

This map shows the geographic impact of Yoshiaki Monden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Monden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Monden more than expected).

Fields of papers citing papers by Yoshiaki Monden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Monden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Monden. The network helps show where Yoshiaki Monden may publish in the future.

Co-authorship network of co-authors of Yoshiaki Monden

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Monden. A scholar is included among the top collaborators of Yoshiaki Monden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Monden. Yoshiaki Monden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ciomei, Marina, Valter Croci, Enrico Pesenti, et al.. (2004). Antitumor efficacy of edotecarin in combination with other cytotoxic drugs.. 64. 483–483. 1 indexed citations
2.
3.
Asagoshi, Kenjiro, Takao Yamada, Hiroaki Terato, et al.. (2000). Distinct Repair Activities of Human 7,8-Dihydro-8-oxoguanine DNA Glycosylase and Formamidopyrimidine DNA Glycosylase for Formamidopyrimidine and 7,8-Dihydro-8-oxoguanine. Journal of Biological Chemistry. 275(7). 4956–4964. 104 indexed citations
4.
Takaku, Kazuaki, et al.. (2000). A Mutant Escherichia coli Tyrosyl-tRNA Synthetase Utilizes the Unnatural Amino Acid Azatyrosine More Efficiently than Tyrosine. Journal of Biological Chemistry. 275(51). 40324–40328. 41 indexed citations
5.
Minowa, Osamu, Tsuyoshi Arai, Masanori Hirano, et al.. (2000). Mmh / Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proceedings of the National Academy of Sciences. 97(8). 4156–4161. 301 indexed citations
6.
Monden, Yoshiaki, et al.. (1999). Azatyrosine: Mechanism of Action for Conversion of Transformed Phenotype to Normal. Annals of the New York Academy of Sciences. 886(1). 109–121. 10 indexed citations
7.
Monden, Yoshiaki, Tsuyoshi Arai, Midori Asano, et al.. (1999). Human MMH (OGG1) Type 1a Protein Is a Major Enzyme for Repair of 8-Hydroxyguanine Lesions in Human Cells. Biochemical and Biophysical Research Communications. 258(3). 605–610. 49 indexed citations
8.
Satoh, Toshihiko, Hiroharu Arakawa, Ikuko Suzuki‐Takahashi, et al.. (1998). J-104,871, a Novel Farnesyltransferase Inhibitor, Blocks Ras Farnesylation In Vivo in a Farnesyl Pyrophosphate-Competitive Manner. Molecular Pharmacology. 54(1). 1–7. 31 indexed citations
9.
Aoyama, Tetsuya, Toshihiko Satoh, Katsumasa Nonoshita, et al.. (1998). A New Class of Highly Potent Farnesyl Diphosphate-Competitive Inhibitors of Farnesyltransferase. Journal of Medicinal Chemistry. 41(2). 143–147. 16 indexed citations
10.
Nakamura, Takao, Midori Asano, Nobuko Shindo‐Okada, Susumu Nishimura, & Yoshiaki Monden. (1996). Cloning of theRhoB Gene from the Mouse Genome and Characterization of Its Promoter Region. Biochemical and Biophysical Research Communications. 226(3). 688–694. 9 indexed citations
11.
Nakamura, Takao, Yoshiaki Monden, Kazuko Kawashima, Tsuguo Naruke, & S Nishimura. (1996). Failure to Detect Mutations in the Retinoblastoma Protein‐binding Domain of the Transcription Factor E2F‐1 in Human Cancers. Japanese Journal of Cancer Research. 87(12). 1204–1209. 3 indexed citations
12.
Monden, Yoshiaki, T. Nakamura, KATSUHISA KOJIRI, Nobuko Shindo‐Okada, & S Nishimura. (1996). Stimulation of the expression of rhoB contributes to the ability of azatyrosine to convert c-erbB-2-transformed cells to a normal morphology. Oncology Reports. 3(1). 49–55. 2 indexed citations
13.
Monden, Yoshiaki, Taishi Nakamura, KATSUHISA KOJIRI, Nobuko Shindo‐Okada, & S Nishimura. (1996). Azatyrosine is incorporated into proteins instead of tyrosine residues, with the resultant conversion of transformed cells to cells with a normal phenotype. Oncology Reports. 3(4). 625–9. 5 indexed citations
14.
Monden, Yoshiaki, Toru Nakamura, KATSUHISA KOJIRI, Nobuko Shindo‐Okada, & S Nishimura. (1996). Azatyrosine inhibits the activation of c-Raf-1, c-Jun and AP1 but not the activation of Ras during signal transduction triggered by oncogenic c-ErbB-2. Oncology Reports. 3(1). 33–40. 3 indexed citations
15.
Futamura, Mayumi, et al.. (1995). Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells.. PubMed. 10(6). 1119–23. 55 indexed citations
16.
17.
Okura, Akira, Hiroharu Arakawa, Hirofumi Oka, Tomoko Yoshinari, & Yoshiaki Monden. (1988). Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cells. Biochemical and Biophysical Research Communications. 157(1). 183–189. 363 indexed citations
18.
Aiba, Shuichi, et al.. (1986). Stabilisation in bacillus stearothermophilus of a recombinant plasmid carrying the homologous α‐amylase gene. Journal of Chemical Technology & Biotechnology. 36(12). 599–609. 6 indexed citations
19.
Koizumi, Jun‐ichi, Yoshiaki Monden, & Shuichi Aiba. (1985). Effects of temperature and dilution rate on the copy number of recombinant plasmid in continuous culture of Bacillus stearothermophilus (pLP11). Biotechnology and Bioengineering. 27(5). 721–728. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Strunck Breakdown of academic impact, for papers by Michitaka Numoto Breakdown of academic impact, for papers by Debra L. Bemis Breakdown of academic impact, for papers by Shigetoshi Hosaka Breakdown of academic impact, for papers by Rhoderick H. Elder Breakdown of academic impact, for papers by Adil Akhtar Breakdown of academic impact, for papers by P Kolachana Breakdown of academic impact, for papers by C. Richard Boland Breakdown of academic impact, for papers by Sara Antonia Li Breakdown of academic impact, for papers by Jerome F. Sah
Rankless by CCL
2026